Primary canaliculitis. 2009

Renzo A Zaldívar, and Elizabeth A Bradley
Department of Ophthalmology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA. zaldivar.renzo@gmail.com

OBJECTIVE To review the clinical findings, treatment outcomes, and microbiology of primary canaliculitis. METHODS A medical record database was queried to identify cases of primary canaliculitis. The 23 cases identified were reviewed for clinical presentation, treatment, microbiology, pathology, and patient outcome at the time of most recent follow-up. Participants were also surveyed to determine long-term treatment outcomes. RESULTS Twenty-three patients met the criteria for primary canaliculitis. The median duration of symptoms was 135 days. The most common symptoms were mattering and epiphora. Punctal regurgitation was the most common clinical finding. Seven patients had multiple canalicular involvement. Treatment included either medical therapy or surgical intervention. Cultures were obtained from 16 participants. Sixty-two percent of identified organisms were gram positive, and most organisms were anaerobes or facultative anaerobes. The most common organisms identified were Streptococcus and Staphylococcus species. Actinomyces and Propionibacterium species followed. Actinomyces israelii was not cultured. Eighteen patients responded to a mailed survey (response rate, 67%). Most respondents (83%) denied having either epiphora or mattering at median 90 months follow-up. Three of the respondents reported having had an additional episode of canaliculitis since last clinical follow-up. Two of these occurred in a previously uninvolved punctum. CONCLUSIONS Although involvement of multiple canaliculi over time is more common than previously recognized, most patients do not have lingering problems with epiphora or mattering. The microbiology of primary canaliculitis does not appear to be evolving, with Actinomyces, and other anaerobes or facultative anaerobes being common pathogens.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003607 Dacryocystitis Inflammation of the lacrimal sac. (Dorland, 27th ed) Dacryoadenitis,Dacryoadenitides,Dacryocystitides
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Renzo A Zaldívar, and Elizabeth A Bradley
December 2023, Ophthalmic plastic and reconstructive surgery,
Renzo A Zaldívar, and Elizabeth A Bradley
March 2018, Journal of current ophthalmology,
Renzo A Zaldívar, and Elizabeth A Bradley
October 2017, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie,
Renzo A Zaldívar, and Elizabeth A Bradley
January 2012, Ophthalmic plastic and reconstructive surgery,
Renzo A Zaldívar, and Elizabeth A Bradley
January 2011, Survey of ophthalmology,
Renzo A Zaldívar, and Elizabeth A Bradley
April 2023, Experimental and therapeutic medicine,
Renzo A Zaldívar, and Elizabeth A Bradley
June 2023, Turkish journal of ophthalmology,
Renzo A Zaldívar, and Elizabeth A Bradley
June 2022, Pathology,
Renzo A Zaldívar, and Elizabeth A Bradley
March 1963, Ceskoslovenska oftalmologie,
Copied contents to your clipboard!